These findings suggest that purine degradation products (e.g., uric acid) may serve as biomarkers of HIE severity and suggest that modulation of xanthine oxidase activity or enhancement of the purine cycle may alleviate energy depletion. The gene discussed is XDH; the disease is perinatal asphyxia.